Frankfurt - Delayed Quote EUR

Genomma Lab Internacional, S.A.B. de C.V. (GEKA.F)

0.9750

-0.0250

(-2.50%)

As of 9:06:07 AM GMT+2. Market Open.

Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortization of the LAB 23 bond

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, announces the successful placement of unsecured Mexican corporate bonds (Cebures) for a total amount of MXN $1,200,000,000.00 (One billion two hundred million pesos 00/100 M.N.).

PR Newswire 4 hours ago

GNMLF
Genomma Lab Internacional SAB de CV (GNMLF) Q1 2025 Earnings Call Highlights: Strong Revenue ...

Genomma Lab Internacional SAB de CV (GNMLF) reports robust sales and market expansion, but faces challenges with raw material costs and currency fluctuations.

GuruFocus.com last month

GNMLF
Genomma Lab Internacional Announces Results for the First Quarter 2025

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2025. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.

PR Newswire last month

GNMLF
Genomma Lab Internacional S.A.B. de C.V. First Quarter 2025 Earnings Results Conference Call

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2025 Earnings Results on Wednesday, April 30, 2025, after the Mexican Stock Exchange (BMV) close. The company also announced that it will hold a conference call on Friday, May 02, 2025, at 11 a.m. Mexico City Time to discuss its quarterly financial results.

PR Newswire 2 months ago

GNMLF
Global Market: 3 Stocks That May Be Trading Below Their Estimated Value

In recent weeks, global markets have been marked by volatility, with U.S. stocks experiencing losses amid inflation concerns and trade policy uncertainties. As investors navigate these challenging conditions, opportunities may arise in the form of undervalued stocks that could offer potential value based on their current trading prices relative to intrinsic worth.

Simply Wall St. 2 months ago

GNMLF

GMXTF
GENOMMA LAB INTERNACIONAL ANNOUNCES ELEVENTH DIVIDEND PAYMENT

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Cu

PR Newswire 2 months ago

GNMLF
Genomma Lab Internacional SAB de CV (GNMLF) Q4 2024 Earnings Call Highlights: Record Growth and ...

Genomma Lab Internacional SAB de CV (GNMLF) reports robust sales growth, significant profitability gains, and strategic plans for future expansion.

GuruFocus.com 3 months ago

GNMLF
Genomma Lab Internacional Announces Results for the Fourth Quarter and Full Year 2024

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the fourth quarter and full year ended December 31, 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.

PR Newswire 3 months ago

GNMLF
Genomma Lab Internacional S.A.B. de C.V. Fourth Quarter 2024 Earnings Results Conference Call

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Fourth Quarter 2024 Earnings Results on Wednesday, February 26, 2025, after the Mexican Stock Exchange (BMV) close. The company also announced that it will hold a conference call on Thursday, February 27, 2025, at 11:00 a.m. Mexico City Time to discuss its quarterly financial results.

PR Newswire 3 months ago

GNMLF
3 Stocks That May Be Priced Below Their Estimated Value In January 2025

As global markets navigate a mixed economic landscape marked by resilient labor markets and inflationary pressures, investors are closely monitoring the impact of these factors on stock valuations. With U.S. equities experiencing volatility and small-cap stocks underperforming, there is growing interest in identifying stocks that may currently be priced below their estimated value. In such an environment, a good stock often exhibits strong fundamentals, resilience to market fluctuations, and...

Simply Wall St. 4 months ago

GNMLF

LABFF
3 Growth Companies Insiders Own With Up To 30% Earnings Growth

In a week marked by cautious commentary from the Federal Reserve and political uncertainty surrounding a potential government shutdown, global markets experienced notable volatility. Despite these challenges, robust economic data such as stronger-than-expected GDP growth and retail sales figures provided some optimism amidst the turmoil. In this environment, identifying growth companies with high insider ownership can be particularly appealing, as insiders' confidence in their own companies...

Simply Wall St. 5 months ago

LCTSF

GNMLF
3 Stocks That May Be Trading At Discounts Of Up To 42.1%

In a week marked by mixed performances across major U.S. indices, with growth stocks significantly outpacing their value counterparts, investors are keenly observing the potential for undervalued opportunities amidst market volatility. As geopolitical tensions and economic data continue to shape the global landscape, identifying stocks that may be trading at a discount could offer strategic entry points for those looking to capitalize on market inefficiencies.

Simply Wall St. 5 months ago

GNMLF
Three Stocks That Might Be Undervalued According To Current Market Analysis

As global markets react to recent political shifts and economic policy changes, investors are keenly observing the implications of a "red sweep" in the U.S., which has driven major indices like the S&P 500 to record highs. Amidst this environment, identifying potentially undervalued stocks becomes crucial as investors look for opportunities that may benefit from anticipated regulatory and tax reforms.

Simply Wall St. 6 months ago

GNMLF
Top Growth Companies With Insider Ownership In October 2024

As global markets navigate the impact of rising U.S. Treasury yields, with growth stocks showing resilience amidst broader economic challenges, investors are increasingly attentive to companies with strong insider ownership—a potential indicator of confidence and alignment between management and shareholders. In this climate, identifying growth companies where insiders hold significant stakes can be particularly appealing, as these firms may exhibit robust leadership commitment and strategic...

Simply Wall St. 6 months ago

GNMLF
Genomma Lab Internacional SAB de CV (GNMLF) Q3 2024 Earnings Call Highlights: Strong Financial ...

Genomma Lab Internacional SAB de CV (GNMLF) reports robust revenue growth, improved margins, and strategic expansions despite regional challenges.

GuruFocus.com 7 months ago

GNMLF
Genomma Lab Internacional Announces Results for the Third Quarter 2024

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the second quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned.

PR Newswire 7 months ago

GNMLF
Genomma Lab Internacional SAB de CV (GNMLF) Q2 2024 Earnings Call Highlights: Robust Growth and ...

Genomma Lab Internacional SAB de CV (GNMLF) reports significant improvements in margins and net income, while navigating macroeconomic challenges and strategic acquisitions.

GuruFocus.com 7 months ago

GNMLF
Genomma Lab Internacional S.A.B. de C.V. Third Quarter 2024 Earnings Results Conference Call

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Third Quarter 2024 Earnings Results on Wednesday, October 23, 2024, after the Mexican Stock Exchange (BMV) close. The company also announced that it will hold a conference call on Thursday, October 24, 2024, at 1 p.m. ET to discuss its quarterly financial results.

PR Newswire 7 months ago

GNMLF
GENOMMA LAB PHARMA MANUFACTURING FACILITY GRANTED PENDING GMP CERTIFICATION FOR THE MEXICAN MARKET

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced that it has received Good Manufacturing Practices ("GMP") certification from the Mexican Ministry of Health's Federal Committee for Protection from Sanitary Risks for its oral liquid, topical liquid and tablet coating manufacturing production at Genomma Lab's Medicinas y Me

PR Newswire 7 months ago

GNMLF
GENOMMA LAB INTERNACIONAL ANNOUNCES NINTH DIVIDEND PAYMENT

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Cu

PR Newswire 8 months ago

GNMLF

Performance Overview

Return	GEKA.F	S&P/BMV IPC (^MXX)
YTD	+2.94%	+16.29%
1-Year	+196.40%	+7.66%
3-Year	+2,895.17%	+13.60%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Genomma Lab Internacional, S.A.B. de C.V. (GEKA.F)

Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortization of the LAB 23 bond

Genomma Lab Internacional SAB de CV (GNMLF) Q1 2025 Earnings Call Highlights: Strong Revenue ...

Genomma Lab Internacional Announces Results for the First Quarter 2025

Genomma Lab Internacional S.A.B. de C.V. First Quarter 2025 Earnings Results Conference Call

Global Market: 3 Stocks That May Be Trading Below Their Estimated Value

GENOMMA LAB INTERNACIONAL ANNOUNCES ELEVENTH DIVIDEND PAYMENT

Genomma Lab Internacional SAB de CV (GNMLF) Q4 2024 Earnings Call Highlights: Record Growth and ...

Genomma Lab Internacional Announces Results for the Fourth Quarter and Full Year 2024

Genomma Lab Internacional S.A.B. de C.V. Fourth Quarter 2024 Earnings Results Conference Call

3 Stocks That May Be Priced Below Their Estimated Value In January 2025

3 Growth Companies Insiders Own With Up To 30% Earnings Growth

3 Stocks That May Be Trading At Discounts Of Up To 42.1%

Three Stocks That Might Be Undervalued According To Current Market Analysis

Top Growth Companies With Insider Ownership In October 2024

Genomma Lab Internacional SAB de CV (GNMLF) Q3 2024 Earnings Call Highlights: Strong Financial ...

Genomma Lab Internacional Announces Results for the Third Quarter 2024

Genomma Lab Internacional SAB de CV (GNMLF) Q2 2024 Earnings Call Highlights: Robust Growth and ...

Genomma Lab Internacional S.A.B. de C.V. Third Quarter 2024 Earnings Results Conference Call

GENOMMA LAB PHARMA MANUFACTURING FACILITY GRANTED PENDING GMP CERTIFICATION FOR THE MEXICAN MARKET

GENOMMA LAB INTERNACIONAL ANNOUNCES NINTH DIVIDEND PAYMENT

Performance Overview